ATORX — Alligator Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK105.65m
- SEK105.06m
- SEK0.51m
Brief: Alligator Bioscience Secures 85% Of Warrant Programme TO 12
Brief: Alligator Bioscience Q1 Operating Loss Lowers To SEK 43.7 Mln
Brief: Alligator Bioscience Sets Record Date For Reverse Share Split On April 8
Brief: Alligator Bioscience CMO Leaves
Brief: Alligator Bioscience Announces FDA Orphan Drug Designation For HLX22/AC101
Brief: Alligator Bioscience Announces Continued Overall Survival Benefit For Mitazalimab
Brief: Alligator Bioscience Proposes Reverse Share Split
Brief: Alligator Bioscience Resolved On Directed Issue Of 84,560,000 Units
Brief: Alligator Bioscience To Get SEK 153 Mln From Rights Issue
Brief: Alligator Bioscience To Initiate Phase 3 For Mitazalimab in 2025
Brief: Alligator Bioscience Q4 EBIT SEK -60.1 Million
Brief: Alligator Bioscience Announces Final Terms Of Rights Issue
Brief: Alligator Bioscience Carries Out Rights Issue Of About SEK 280 Mln
Brief: Alligator Bioscience EGM To Be Held On Monday, Jan 13, 2025
Brief: Alligator Says May Lay Off About 70% Of Current Workforce
Brief: Orion And Alligator Bioscience Amend Their Agreement Concerning Two Bispecific Antibodies
Brief: Alligator Bioscience Says Alg.Apv-527 Meets Phase 1 Trial Endpoints
Brief: Alligator Bioscience Q3 EBIT SEK -62 Million
Brief: Alligator Bioscience, Aptevo Therapeutics Announce Positive Interim Data From Dose Escalation Phase Of Their Phase 1 Trial